Vetrepharm ApS: Financial statements 2019
CVR: 15206802
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Vetrepharm ApS (CVR 15206802) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -39,654 and a net result of DKK -84,121 compared with DKK -199,932 the year before. Equity in the 2019 report amounted to DKK -14,643. The company had 1 employee in the financial year.
- Gross Profit
- DKK -39,654
- Profit/Loss
- DKK -84,121
- Equity
- DKK -14,643
- Total Assets
- DKK 62,993
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -40 t. | -84 t. | -15 t. | 1 |
| 2018 | - | -120 t. | -200 t. | 919 t. | 1 |
| 2017 | - | 129 t. | 42 t. | 1.1 mio. | 1 |
| 2016 | - | 50 t. | -26 t. | 1.1 mio. | 1 |
| 2015 | - | 678 t. | 200 t. | 1.6 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Vetrepharm ApS has published its annual report for 2018. Gross profit came to DKK -119,626, and the net result was DKK -199,932.
About Vetrepharm ApS
Vetrepharm ApS was a Danish company of the type Anpartsselskab based in Brande, founded in 1991. The company has been dissolved on 4 October 2021. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VETREPHARM A/S and A/S PSE NR. 4365. The company has 1 employee (2020). In 2019, the company reported a gross profit of DKK -39,654 and a net result of DKK -84,121 compared with DKK -199,932 the year before. Equity in the 2019 report amounted to DKK -14,643.